USSTOCK.TODAY
Weekend. Closed
Log in Sign up

Colossal Biosciences expands de-extinction and biotechnology

CNBC ·

  1. 1Colossal Biosciences is conducting the Dire Wolf project using ancient DNA and has produced three offspring via surrogacy.
  2. 2The company has raised a total of over $435 million since its inception, including a $200 million Series C investment in July.
  3. 3While Colossal's valuation reached $10.2 billion, Astromech achieved a $2 billion valuation in March.

So what's the key point?

Colossal Biosciences has produced offspring of extinct animals using ancient genes. This company has received a total of over $435 million in investment to date.

Source CNBC · View original ↗

Related 3-line summaries

Bloom Energy raises annual guidance as Q2 revenue reaches approximately $1.1 billion Nasdaq +1 · 1h agoTrump Administration Halts Green Card Programs for Foreign Workers at Microsoft and Others Moneywise +1 · 1h agoKraft Heinz Shares Fall Amid Declining Sales Nasdaq +1 · 45m ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news